Literature DB >> 2964518

Duration of ductal shunting in healthy preterm infants: an echocardiographic color flow Doppler study.

M D Reller1, M L Ziegler, M J Rice, R C Solin, R W McDonald.   

Abstract

The purpose of this investigation was to assess the duration of ductal shunting after birth in healthy preterm infants (30 to 37 weeks gestational age) without evidence of respiratory distress. Thirty-six infants were evaluated in the first 12 hours of life by means of two-dimensional echocardiography and color flow Doppler techniques, and then once daily until no ductal flow was detected (defined as functional closure). Preterm infants were subdivided into two groups by gestational age: group 1 = 30 to 33 weeks (n = 12); group 2 = 34 to 37 weeks (n = 24). Sixteen full-term infants (38 to 41 weeks) were similarly evaluated as control subjects (Group 3). One infant from each group had a closed ductus at the time of the first study (performed at a mean of 7.7 +/- 3.2 hours). Subsequent studies for the entire group were performed at a mean of 31.3 +/- 5.4 hours (day 2), 55.0 +/- 4.5 hours (day 3), and 80.3 +/- 6.1 hours (day 4). For the three groups, the rates of ductal closure ranged from 50.0% to 58.3% on day 2 and 81.3% to 87.5% on day 3. For the entire group, all but one infant had demonstrated closure of the ductus arteriosus by day 4. Within the range of gestational ages studied, we conclude that prematurity, in the absence of respiratory distress syndrome, does not prolong the initial duration of physiologic ductal shunting.

Entities:  

Mesh:

Year:  1988        PMID: 2964518     DOI: 10.1016/s0022-3476(88)80333-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  20 in total

1.  Intermittent ductal patency in healthy newborn infants: demonstration by colour Doppler flow mapping.

Authors:  M K Lim; K Hanretty; A B Houston; S Lilley; E P Murtagh
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

2.  The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

Authors:  Jeff Reese; Matthew M Laughon
Journal:  J Pediatr       Date:  2015-08-24       Impact factor: 4.406

3.  Usefulness of indomethacin for patent ductus arteriosus in full-term infants.

Authors:  Takeshi Takami; Hitoshi Yoda; Tadashi Kawakami; Hideshi Yamamura; Toshio Nakanishi; Makoto Nakazawa; Yukito Takei; Tasuku Miyajima; Akinori Hoshika
Journal:  Pediatr Cardiol       Date:  2007-01-02       Impact factor: 1.655

4.  Towards rational management of the patent ductus arteriosus: the need for disease staging.

Authors:  Patrick J McNamara; Arvind Sehgal
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-11       Impact factor: 5.747

5.  Bidirectional flow through the ductus arteriosus in normal newborns: evaluation by Doppler color flow imaging.

Authors:  H Shiraishi; M Yanagisawa
Journal:  Pediatr Cardiol       Date:  1991-10       Impact factor: 1.655

6.  Postnatal circulatory adaptation in healthy term and preterm neonates.

Authors:  N J Evans; L N Archer
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

7.  Surfactant and patent ductus arteriosus.

Authors:  Abhay Kumar; Anil Lakkundi; Patrick J McNamara; Arvind Sehgal
Journal:  Indian J Pediatr       Date:  2010-01-20       Impact factor: 1.967

Review 8.  Diagnosis of patent ductus arteriosus in the preterm newborn.

Authors:  N Evans
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

9.  Improving maternal-infant bonding after prenatal diagnosis of CHD.

Authors:  Piers C A Barker; Gregory H Tatum; Michael J Campbell; Michael G W Camitta; Angelo S Milazzo; Christoph P Hornik; Amanda French; Stephen G Miller
Journal:  Cardiol Young       Date:  2018-08-06       Impact factor: 1.093

10.  Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.

Authors:  Chuan-Zhong Yang; Jiun Lee
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.